Cite
HARVARD Citation
Schmiegel, W. et al. (2017). Blood‐based detection of RAS mutations to guide anti‐EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue‐based RAS testing. Molecular oncology. 11 (2), pp. 208-219. [Online].